Cortney Caudill
Directeur des opérations chez HALOZYME THERAPEUTICS, INC.
Profil
Cortney Caudill is currently the Chief Operations Officer at Halozyme Therapeutics, Inc. Previously, Cortney held positions as the Director-Business Development Technology at SAMSUNG BIOLOGICS Co., Ltd., Principal at Genentech, Inc., and Principal at VaxGen, Inc. Cortney also served as the Head-Drug Product External Manufacturing Network at Baxalta Schweiz AG from 2014 to 2016.
Cortney's education includes an MBA from Fordham University and an undergraduate degree from The University of Texas at Austin.
Cortney's current job is Chief Operations Officer at Halozyme Therapeutics, Inc.
Postes actifs de Cortney Caudill
| Sociétés | Poste | Début |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Directeur des opérations | - |
Anciens postes connus de Cortney Caudill
| Sociétés | Poste | Fin |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 06/01/2023 |
| Baxalta Schweiz AG | Corporate Officer/Principal | 01/02/2016 |
VaxGen, Inc.
 VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
| SAMSUNG BIOLOGICS CO.,LTD. | Corporate Officer/Principal | - |
Formation de Cortney Caudill
| Fordham University | Masters Business Admin |
| The University of Texas at Austin | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| SPYRE THERAPEUTICS, INC. | Health Technology |
| SAMSUNG BIOLOGICS CO.,LTD. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
| Baxalta Schweiz AG |
